Bob Roberts

Promotion Mast Energy Developments (MED), a private UK-registered company targeting the development and operation of flexible power plants to service the Reserve Power generation market and balance out the national grid at critical times. MED will be issuing up to 44,320,000 shares to raise up to £5.5M in order to immediately begin producing power and cash flow to fund the existing opportunities shortly after the IPO. MED will acquire and develop a portfolio of flexible, small scale and multiple Reserve Power generation plants throughout the UK producing 300 MW of safe and clean power through natural gas. For the uninitiated, Reserve Power (RP) is the process of timing energy supply so that it can be used during periods of peak demand. It is a clean and stable solution that has growing demand and carries limited risk. The company is potentially in a position to begin generating power and revenue soon after IPO and has a number of shovel-ready sites. Interestingly, comparable companies have enjoyed explosive growth in recent months. Initially, the stock has the potential to be a growth play and as MED develops more power plants and on reaching full capacity, could potentially start paying dividends. MED, which is currently a 100% subsidiary company of Kibo Energy Plc and a 100% holding company of Sloane Developments Ltd., is seeking admission to the Official List of the London Stock Exchange. Louis Coetzee, CEO of Kibo Energy, said, “Following the LSE Admission of MED, MED and Sloane will be in a position to develop its portfolio at scale and pace, as opposed to a project-by-project basis and advance rapidly towards significant revenue generation.” “This is an exciting period for both MED, Sloane and Kibo and we look forward to providing additional updates on further progress made,” he added. Clear Capital Markets is excited to provide its clients with the opportunity to invest in the Initial Public Offering of Mast Energy Development. The sector is extremely popular at present and CCM believes it will remain so for the foreseeable future. Investments in pre-IPO’s and IPO’s involve a high degree of risk and are not suitable for all investors. The value of investments can fall as well as rise. Capital is invested at risk. https://www.clearcapitalmarkets.co.uk/med-to-raise-around-5-5-million-by-issuing-up-to-44320000-shares/